Kalvista Pharmaceuticals Inc (KALV)
Working Capital Ratio
78.36%
Quarterly · Period ending:
KALV Working Capital Ratio
Latest reported78.36%period ending
Latest reported78.36%period ending
KALV Quarterly Working Capital Ratio (58.98% → 78.36%)
Quarterly working capital ratio
High-resolution chart · PNG
KALV working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 78.3577% | |
| 78.3577% | |
| 82.4158% | |
| 77.7342% | |
| 78.3678% | |
| 87.5906% | |
| 80.8942% | |
| 84.5278% | |
| 86.185% | |
| 74.5604% | |
| 79.8995% | |
| 84.6431% | |
| 85.8582% | |
| 88.725% | |
| 85.9112% | |
| 88.128% | |
| 89.303% | |
| 91.0079% | |
| 92.0241% | |
| 93.2158% | |
| 93.558% | |
| 84.5633% | |
| 82.8915% | |
| 85.5379% | |
| 87.5142% | |
| 86.6984% | |
| 86.9343% | |
| 84.8754% | |
| 82.5297% | |
| 83.1749% | |
| 82.3271% | |
| 56.0276% | |
| 58.9096% | |
| 62.4496% | |
| 88.1552% | |
| 85.6127% | |
| 90.9303% | |
| 91.3325% | |
| 94.5877% | |
| 94.7931% | |
| 91.8188% | |
| 89.2289% | |
| 92.8752% | |
| 92.9436% | |
| -86.8387% | |
| -37.7182% | |
| 17.7289% | |
| 58.9807% |